Taking Novo Nordisk’s new obesity drug may help reduce the risk of heart disease as well as boosting weight loss, according to new research from the United States.
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photonew obesity drug may help reduce the risk of heart disease as well as boosting weight loss, according to new research from the United States.
The results, which were presented this week at the European Congress on Obesity in Dublin, are among the first indication that the weight loss induced by the new GLP-1 agonist drugs like Wegovy also brings heart health benefits – something scientists expected, but do not yet have much comprehensive data to prove.
Novo is expected to release results from its 5-year SELECT trial looking into the health impact of its injectable drug, particularly around heart disease, later this year.“It is extremely important, because we know obesity is a risk factor for cardiovascular disease,” Dr Andres Acosta, one of the researchers, told Reuters.
The risk was calculated using the American College of Cardiology’s calculator, based on data including blood pressure and cholesterol levels. The team assessed the risk before the patients – mainly white women, with a mean BMI of 39.8, but no history of heart disease – started the drug as well as after one year of taking it.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Weight Loss Success: Semaglutide Turns the Scales on Teen ObesityNearly Half of Adolescents Using Semaglutide in Trial Dropped Below the Clinical Cut-Off for Obesity A secondary analysis of the STEP TEENS trial, published in the Obesity journal and presented at the European Congress on Obesity 2023, has found that semaglutide is effective in treating obesity i
Baca lebih lajut »
Brentwood mum criticises obesity test that labelled her son overweightAn Essex hairdresser describes her shock at being asked whether her son needs dietary help.
Baca lebih lajut »
Weight loss drug reverses obesity for nearly half of teens in studySemaglutide was recently approved by the FDA to help obese adolescents lose weight. When used to treat diabetes, the drug is sold under the brand name Ozempic.
Baca lebih lajut »
Obesity Drug With Swallowable Balloon Boosts Weight LossA combination of a swallowable Allurion gastric balloon and liraglutide delivers higher weight loss (around 19% after mean 4 months) than use of separate treatments.
Baca lebih lajut »
Half of Teens Drop Below Obesity Cutoff With SemaglutideSemaglutide represents an efficacious treatment option for adolescents with obesity, with the potential to reduce BMI below the obesity threshold.
Baca lebih lajut »
4th XXXTentacion killer gets reduced sentence after taking plea dealA Florida man who testified against three former friends who murdered rap star XXXTentacion will spend two more years behind bars. XXXTentacion kprc2 click2hou
Baca lebih lajut »